NEBL and hypertrophic cardiomyopathy: The pathogenic mutations of NEBL will induce dilated cardiomyopathy, hypertrophic cardiomyopathy, left ventricular non-compaction cardiomyopathy, and endocardial fibroelastosis [24–27].